[1]商 静a,刘 波a,李小侠b,等.陕西职业学校视力残疾学生患非酒精性脂肪肝病及临床实验室相关指标调查[J].现代检验医学杂志,2023,38(03):199-203.[doi:10.3969/j.issn.1671-7414.2023.03.037]
　SHANG Jinga,LIU Boa,LI Xiao-xiab,et al.An Investigation of Non-alcoholic Fatty Liver and Clinical Laboratoryrelated Indicators in Shaanxi Province’s Vocational Students with Visual Disabilities[J].Journal of Modern Laboratory Medicine,2023,38(03):199-203.[doi:10.3969/j.issn.1671-7414.2023.03.037]
点击复制

陕西职业学校视力残疾学生患非酒精性脂肪肝病及临床实验室相关指标调查()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年03期
页码:
199-203
栏目:
检验与临床
出版日期:
2023-05-15

文章信息/Info

Title:
An Investigation of Non-alcoholic Fatty Liver and Clinical Laboratoryrelated Indicators in Shaanxi Province’s Vocational Students with Visual Disabilities
文章编号:
1671-7414（2023）03-199-05
作者:
商 静a; 刘 波a; 李小侠b; 王珍芳a; 张茜茜a; 郭振军c
( 陕西省人民医院a. 超声诊断中心； b. 检验科；c. 药学部，西安 710068)
Author(s):
SHANG Jinga;  LIU Boa;  LI Xiao-xiab;  WANG Zhen-fanga;  ZHANG Xi-xia;  GUO Zhen-junc
（a. Ultrasound Medical Diagnosis Center；b. Department of Clinical Laboratory；c. Department of Pharmacy, Shaanxi Provincial People’s Hospital, Xi’an 710068, China）
关键词:
非酒精性脂肪肝病; 视力残疾; 学生
分类号:
R575.5；R446.11
DOI:
10.3969/j.issn.1671-7414.2023.03.037
文献标志码:
A
摘要:
目的 调查陕西职业学校视力残疾学生非酒精性脂肪肝病(non-alcoholic fatty liver，NAFL) 患病现状及相关临床实验室指标。方法 2021 年10 月对陕西省城市经济学校视力残疾学生集中进行了健康体检，根据肝脏超声结果分为NAFL 组（n=15）和健康组（n=51）。比较两组间NAFL 相关体格测量及实验室指标差异，并采用二元Logistic回归方法分析影响NAFL 发生的独立危险因素。结果 66 例（男38 例，女28 例）15 ～ 35（22±5）岁视力残疾学生的NAFL 患病率为22.7%。NAFL 组学生的体重指数25.5±4.9 kg/m2，腰围83（77，97）cm，收缩压128.4±18.8mmHg，舒张压88±9mmHg，三酰甘油1.9（1.1，2.3）mmol/L，总胆固醇5.0（4.8，5.5）mmol/L，门冬氨酸氨基转移酶27（19，37）U/L，丙氨酸氨基转移酶27（21，34）U/L 及尿酸449.0（386.0，512.0）mmol/L 显著高于健康组[（21.2±2.7kg/m2，74（70，79）cm，117.8±14.5 mmHg，80±13 mmHg，0.9（0.8，1.5）mmol/L，3.8（3.4，4.2）mmol/L，17（15，21）U/L，13（10，18）U/L，370.5（299.3，424.3）mmol/L]， 差异具有统计学意义（t=-4.4 ～-2.3，U=128.5 ～ 215.5，均P ＜ 0.05）。二元Logistic 回归分析显示体重指数（OR=1.6, P=0.002）和三酰甘油（OR=2.4,P=0.002）差异具有统计学意义。结论 陕西省职业学校视力残疾学生NAFL 患病率较高，体重指数和三酰甘油是发生NAFL 的独立危险因素。
Abstract:
Objective To investigate the present prevalence of non-alcoholic fatty liver(NAFL) and its associated laboratory indexes in Shaanxi vocational school students with visual impairment. Methods A survey on the prevalence of NAFL was done in October 2021 among visually disabled vocational students in Shaanxi Urban Economy School. According to the results of liver ultrasound, all subjects were assigned to the NAFL group (n=15) and the health group (n=51). The physical measurements and laboratory index differences between the two groups, and the binary logistic regression was used to analyze the NAFL-related influencing factors. Results Sixty-six students with a mean age of 22 were examined, including 38 males and 28 females who aged from 15 to 35. The prevalence of NALL among these students was 22.7%. NAFL students had higher values of body mass index 25.5±4.9kg/m2, waist circumference 83 (77，97) cm, systolic blood pressure 128.4±18.8 mmHg, diastolic blood pressure 88±9 mmHg, triglycerides 1.9 (1.1，2.3) mmol/L, total cholesterol 5.0 (4.8，5.5) mmol/L, aspartate aminotransferase 27 (19， 37) U/L, alanine aminotransferase 27 (21，34) U/L and uric acid 449.0 (386.0，512.0) mmol/L than healthy students[（21.2±2.7kg/m2，74（70，79）cm，117.8±14.5 mmHg，80±13 mmHg，0.9（0.8，1.5）mmol/L，3.8（3.4，4.2） mmol/L，17（15，21）U/L，13（10，18）U/L，370.5（299.3，424.3）mmol/L], and the differences were statistically significant (t=-4.4 ～ -2.3, U=128.5 ～ 215.5, all P<0.05). Binary logistic regression analysis showed that both body mass index (OR=1.6, P=0.002) and triacylglycerol (OR=2.4, P=0.002) were characteristic variables that affected the state of NAFL.Conclusion The prevalence of NAFL among students with visual disability in vocational schools in Shaanxi Province is high. The body mass index and triacylglycerol are independent risk factors for NAFL.

参考文献/References:

[1] 张悠然, 王倩, 陈刚, 等. 残疾人健康状况研究 - 以 上海市金山区卫镇为例[J]. 残疾人研究, 2017(4): 13-18. ZHANG Youran, WANG Qian, CHEN Gang, et al. Study on health status of people with disabilities: take Wei Town in Jinshan District of Shanghai as an example[J]. Disability Research, 2017(4): 13-18.
[2] 庞洪波, 刘克强, 肖瑞, 等. 2015 ～ 2018 年天津市 城区15 671 名残疾人健康体检结果分析[J]. 中西医 结合心血管病电子杂志,2019,7(5):170-173. PANG Hongbo, LIU Keqiang, XIAO Rui, et al. Analysis of physical examination results of 15 671 disabled persons in urban areas of Tianjin from 2015 to 2018[J] Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine(Electronic),2019, 7(5): 170-173.
[3] 杨静芳. 宁夏吴忠市25546 例残疾人健康体检结果 分析[J]. 中国卫生统计, 2014, 31(1):151-152. YANG Jingfang. Analysis of health examination results of 25546 disabled persons in Wuzhong City,Ningxia[J]. Chinese Journal of Health Statistics, 2014,31(1):151-152.
[4] 吴恒璟, 吴静, 张紫嫣, 等. 上海市中老年残疾人慢 性病共病现状及相关因素的多重对应分析[J]. 中国 慢性病预防与控制, 2022, 30(7):481-484, 490. WU Hengjing, WU Jing, ZHANG Ziyan, et al. Multiple correspondence analysis of the status and related factors of chronic disease comorbidity in middle-aged and elderly residents with disabilities in Shanghai[J]. Chinese Journal of Prevention and Control of Chronic Diseases, 2022, 30(7): 481-484, 490.
[5] 康琦, 张悠然, 白燕, 等. 上海市残疾人健康状况研 究[J]. 中国全科医学, 2016, 19(34):4230-4233, 4239. KANG Qi, ZHANG Youran, BAI Yan, et al. Health status of disabled persons in Shanghai[J].Chinese General Practice, 2016, 19(34):4230-4233,4239.
[6] 邵幼林, 范建高. 非酒精性脂肪性肝病的流行现状 与危害[J]. 中华肝脏病杂志,2019,27(1):10-13. SHAO Youlin, FAN Jiangao. Prevalence and harm of nonalcoholic fatty liver disease[J]. Chinese Journal of Hepatology, 2019, 27(1): 10-13.
[7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会. 非酒精性脂 肪性肝病防治指南(2018 年更新版)[J]. 临床肝胆病 杂志, 2018, 34(5)：947-957. National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee,Chinese Medical Doctor Association . Guidelines of prevention and treatment for nonalcoholic fatty liver disease：a 2018 update[J].Journal of Clinical Hepatology, 2018, 34(5): 947-957.
[8] 范建高. 中国非酒精性脂肪性肝病诊疗指南(2010 年修订版)[J]. 中国医学前沿杂志( 电子版), 2012,4(7):4-10. FAN Jiangao. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2012, 4(7): 4-10.
[9] 世界卫生组织. 世界卫生组织2014~2021 年全球残 疾问题行动计划: 增强所有残疾人的健康[J]. 中国 康复, 2014, 29(6)：478-479. World Health Organization’s. World Health Organization global plan of action on disability 2014-2021: Improving health for all persons with disabilities[J]. Chinese Journal of Rehabilitation, 2014,29(6)：478-479.
[10] 中华人民共和国国家统计局, 第二次全国残疾人抽 样调查领导小组. 2006 年第二次全国残疾人抽样 调查主要数据公报[J]. 中国康复理论与实践, 2006,12(12)：1013. Leading Group of the Second China National Sample Survey on Disability, National Bureau of Statistics of the People’s Republic of China. Communiqué on major statistics of the second China national sample survey on disability[J]. Chinese Journal of Rehabilitation Theory and Practice, 2006, 12(12)：1013.
[11] 晋一. 教育部等部门联合印发《“十四五”特殊 教育发展提升行动计划》[J]. 青春期健康：家庭文 化,2022,20(7):31. JING Yi. The Ministry of Education and other departments jointly issued the 14th Five-Year Action Plan for the Development and Improvement of Special Education[J].Adolescent Health, 2022, 20(7):31.
[12] 延华, 鲁晓岚, 罗金燕, 等. 陕、甘两省酒精性与非 酒精性脂肪肝流行病学分析[J]. 胃肠病学和肝病学 杂志, 2007, 16(4): 347-350, 353. YAN Hua, LU Xiaolan, LUO Jinyan, et al. Epidemiological analysis of alcoholic and nonalcoholic fatty liver in Shanxi and Gansu province[J]. Chinese Journal of Gastroenterology and Hepatology,2007, 16(4): 347-350, 353.
[13] FUNG J, LEE C K, CHAN M, et al. High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census[J]. Liver International, 2015, 35(2): 542-549.
[14] 蔡美娟, 孔祥楠, 赵晓云. 性别及年龄对非酒精性脂 肪肝患病情况及伴发疾病的影响[J]. 中国医学科学 院学报, 2017, 39(4): 499-505. CAI Meijuan, KONG Xiangnan, ZHAO Xiaoyun. Influences of gender and age on the prevalence and complications of nonalcoholic fatty liver disease[J]. Acta Academiae Medicinae Sinicae, 2017, 39(4): 499-505.
[15] 仝小玲, 张连文. 中青年人群非酒精性脂肪肝患 病现状及影响因素分析[J]. 解放军预防医学杂志,2021, 39(1): 70-72. TONG Xiaoling, ZHANG Lianwen. Analysis of nonalcoholic fatty liver disease and its influencing factors in young and middle-aged population[J]. Journal of Preventive Medicine of Chinese People’s Liberation Army, 2021, 39(1)： 70-72.
[16] 宋燕, 邵冬华, 何美琳, 等. PNPLA3 基因多态性与 非酒精性脂肪性肝病关系的初步探讨[J]. 现代检验 医学杂志, 2016, 31(4): 5-9. SONG Yan, SHAO Donghua, HE Meilin, et al. Preliminary discussion of the relationship between PNPLA3 polymorphism and NAFLD[J]. Journal of Modern Laboratory Medicine, 2016, 31(4): 5-9.
[8] KAWAMURA M, FUKUDA N, SUZUKI A, et al. Use of fibrin monomer complex for screening for venous thromboembolism in the late pregnancy and post-partum period[J]. The Journal of Obstetrics and Gynaecology Research, 2014, 40(3): 700-704.
[9] FORD H L, CHAMPION I, WAN Anna, et al. Predictors for insulin use in gestational diabetes mellitus[J]. European Journal of Obstetrics,Gynecology, and Reproductive Biology, 2022, 272: 177-181.
[10] SUBIABRE M, SILVA L, TOLEDO F, et al. Insulin therapy and its consequences for the mother, foetus, and newborn in gestational diabetes mellitus[J]. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018, 1864(9): 2949-2956.
[11] GORAR S, ALIOGLU B, ADEMOGLU E, et al. Is there a tendency for thrombosis in gestational diabetes mellitus?[J]. Journal of Laboratory Physicians, 2016,8(2): 101-105.
[12] 孔令英, 杨慧霞, 魏玉梅. 正常孕妇早、晚孕期凝 血指标变化[J]. 中华围产医学杂志，2019，22(12): 867-871. KONG Lingying, YANG Huixia, WEI Yumei. Variations of coagulation biochemical markers in normal pregnant women in early and late pregnancy[J]. Chinese Journal of Perinatal Medicine, 2019, 22(12): 867-871.
[13] SIENNICKA A, K?YSZ M, CHE?STOWSKI K, et al. Reference values of D-Dimers and fibrinogen in the course of physiological pregnancy: the potential impact of selected risk factors-A pilot study[J]. Biomed Res Int, 2020, 2020: 3192350.
[14] KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC)[J]. European Respiratory Journal,2019, 54(3): 1901647.
[15] JOHNSON E D, SCHELL J C, RODGERS G M. The D-Dimer assay[J]. American Journal of Hematology,2019, 94(7): 833-839.
[16] GUTI?RREZ GARC?A I, P?REZ CA?ADAS P,MART?NEZ URIARTE J, et al. D-Dimer during pregnancy: establishing trimester-specific reference intervals[J]. Scandinavian Journal of Clinical and Laboratory Investigation, 2018, 78(6): 439-442.
[17] REFAAI M A, RILEY P, MARDOVINA T, et al. The clinical significance of fibrin monomers[J]. Thrombosis and Haemostasis, 2018, 118(11): 1856-1866.
[18] LALLUKKA S, LUUKKONEN P K, ZHOU You,et al. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans[J]. Thrombosis and Haemostasis, 2017, 117(2): 286-294.
[19] 吴曼莉, 赵敏, 袁媛．妊娠期高血糖患者血浆同型 半胱氨酸水平和脐动脉血流参数改变的相关性[J]. 现代检验医学杂志, 2019, 34(3): 96-98, 103. WU Manli, ZHAO Min, YUAN Yuan. Correlation analysis of homocysteine and changes in umbilical arterial with color doppler ultrasound with gestational diabetes mellitus[J]. Journal of Modern Laboratory Medicine, 2019, 34(3): 96-98, 103.
[20] JENNY L, MELMER A, LAIMER M, et al. Diabetes affects endothelial cell function and alters fibrin clot formation in a microvascular flow model: A pilot study[J]. Diabetes & Vascular Disease Research, 2020,17(1): 1479164120903044.
[21] 周青, 秦智娟, 马宗丽．妊娠期糖尿病患者血清 miR-450a-5p 和CREB 表达水平及临床意义[J]. 现 代检验医学杂志, 2022, 37(4): 102-106. ZHOU Qing, QIN Zhijuan, MA Zongli. Expression levels and clinical significance of serum miR-450a- 5p and CREB in patients with gestational diabetes mellitus[J]. Journal of Modern Laboratory Medicine,2022, 37(4): 102-106.

相似文献/References:

[1]李 轶a,尚 立b.非酒精性脂肪肝病患者血清LncRNA PVT1 表达水平与胰岛素抵抗及肝纤维化的相关性研究[J].现代检验医学杂志,2023,38(05):80.[doi:10.3969/j.issn.1671-7414.2023.05.015]
　LI Yia,SHANG Lib.Correlation of Serum LncRNA PVT1 Expression Level with Insulin Resistance and Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease[J].Journal of Modern Laboratory Medicine,2023,38(03):80.[doi:10.3969/j.issn.1671-7414.2023.05.015]

备注/Memo

备注/Memo:
基金项目： 陕西省人民医院科技人才支持计划（2022JY-22）。
作者简介：商 静(1987-)，女，博士，主治医师，研究方向：超声诊断及超声介入，E-mail：373034990@qq.com。
通讯作者：郭振军(1982-)，男，博士，副主任药师，研究方向：临床药学，E-mail：guozhenjun@126.com。
更新日期/Last Update: 2023-05-15